Babies born with congenital pulmonary valve disease (CPVD) face a lifetime burden of disease and significant medical expense beginning in their first year of life. Hopewell Economics assisted with the publication of a peer-reviewed paper appearing on the Journal of Health Economics and Outcomes Research.
The project found that lifetime costs and burden of care for patients with CPVD exceeded $2 million. Babies with CPVD often face considerable hospitalizations in their first years of life. In highlighting the considerable lifetime costs, this study highlights the need for better, earlier intervention in treating such patients.
The research paper is here